181 related articles for article (PubMed ID: 12637506)
1. Apolipoprotein A5, a crucial determinant of plasma triglyceride levels, is highly responsive to peroxisome proliferator-activated receptor alpha activators.
Vu-Dac N; Gervois P; Jakel H; Nowak M; Bauge E; Dehondt H; Staels B; Pennacchio LA; Rubin EM; Fruchart-Najib J; Fruchart JC
J Biol Chem; 2003 May; 278(20):17982-5. PubMed ID: 12637506
[TBL] [Abstract][Full Text] [Related]
2. The human apolipoprotein AV gene is regulated by peroxisome proliferator-activated receptor-alpha and contains a novel farnesoid X-activated receptor response element.
Prieur X; Coste H; Rodriguez JC
J Biol Chem; 2003 Jul; 278(28):25468-80. PubMed ID: 12709436
[TBL] [Abstract][Full Text] [Related]
3. Thyroid hormone regulates the hypotriglyceridemic gene APOA5.
Prieur X; Huby T; Coste H; Schaap FG; Chapman MJ; Rodríguez JC
J Biol Chem; 2005 Jul; 280(30):27533-43. PubMed ID: 15941710
[TBL] [Abstract][Full Text] [Related]
4. Fibrates increase human REV-ERBalpha expression in liver via a novel peroxisome proliferator-activated receptor response element.
Gervois P; Chopin-Delannoy S; Fadel A; Dubois G; Kosykh V; Fruchart JC; Najïb J; Laudet V; Staels B
Mol Endocrinol; 1999 Mar; 13(3):400-9. PubMed ID: 10076997
[TBL] [Abstract][Full Text] [Related]
5. Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor.
Vu-Dac N; Schoonjans K; Kosykh V; Dallongeville J; Fruchart JC; Staels B; Auwerx J
J Clin Invest; 1995 Aug; 96(2):741-50. PubMed ID: 7635967
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein AV does not contribute to hypertriglyceridaemia or triglyceride lowering by dietary fish oil and rosiglitazone in obese Zucker rats.
Dorfmeister B; Brandlhofer S; Schaap FG; Hermann M; Fürnsinn C; Hagerty BP; Stangl H; Patsch W; Strobl W
Diabetologia; 2006 Jun; 49(6):1324-32. PubMed ID: 16570166
[TBL] [Abstract][Full Text] [Related]
7. Fibrates suppress fibrinogen gene expression in rodents via activation of the peroxisome proliferator-activated receptor-alpha.
Kockx M; Gervois PP; Poulain P; Derudas B; Peters JM; Gonzalez FJ; Princen HM; Kooistra T; Staels B
Blood; 1999 May; 93(9):2991-8. PubMed ID: 10216095
[TBL] [Abstract][Full Text] [Related]
8. Fibrate-modulated expression of fibrinogen, plasminogen activator inhibitor-1 and apolipoprotein A-I in cultured cynomolgus monkey hepatocytes -- role of the peroxisome proliferator-activated receptor-alpha.
Kockx M; Princen HM; Kooistra T
Thromb Haemost; 1998 Dec; 80(6):942-8. PubMed ID: 9869165
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte nuclear factor-4alpha regulates the human apolipoprotein AV gene: identification of a novel response element and involvement in the control by peroxisome proliferator-activated receptor-gamma coactivator-1alpha, AMP-activated protein kinase, and mitogen-activated protein kinase pathway.
Prieur X; Schaap FG; Coste H; Rodríguez JC
Mol Endocrinol; 2005 Dec; 19(12):3107-25. PubMed ID: 16051671
[TBL] [Abstract][Full Text] [Related]
10. The liver X receptor ligand T0901317 down-regulates APOA5 gene expression through activation of SREBP-1c.
Jakel H; Nowak M; Moitrot E; Dehondt H; Hum DW; Pennacchio LA; Fruchart-Najib J; Fruchart JC
J Biol Chem; 2004 Oct; 279(44):45462-9. PubMed ID: 15317819
[TBL] [Abstract][Full Text] [Related]
11. Negative regulation of the human apolipoprotein A-I promoter by fibrates can be attenuated by the interaction of the peroxisome proliferator-activated receptor with its response element.
Vu-Dac N; Schoonjans K; Laine B; Fruchart JC; Auwerx J; Staels B
J Biol Chem; 1994 Dec; 269(49):31012-8. PubMed ID: 7983038
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor alpha induces hepatic expression of the human bile acid glucuronidating UDP-glucuronosyltransferase 2B4 enzyme.
Barbier O; Duran-Sandoval D; Pineda-Torra I; Kosykh V; Fruchart JC; Staels B
J Biol Chem; 2003 Aug; 278(35):32852-60. PubMed ID: 12810707
[TBL] [Abstract][Full Text] [Related]
13. Cell culture conditions determine apolipoprotein CIII secretion and regulation by fibrates in human hepatoma HepG2 cells.
Clavey V; Copin C; Mariotte MC; Baugé E; Chinetti G; Fruchart J; Fruchart JC; Dallongeville J; Staels B
Cell Physiol Biochem; 1999; 9(3):139-49. PubMed ID: 10494028
[TBL] [Abstract][Full Text] [Related]
14. Atheroprotective effect of human apolipoprotein A5 in a mouse model of mixed dyslipidemia.
Mansouri RM; Baugé E; Gervois P; Fruchart-Najib J; Fiévet C; Staels B; Fruchart JC
Circ Res; 2008 Aug; 103(5):450-3. PubMed ID: 18658049
[TBL] [Abstract][Full Text] [Related]
15. Effect of peroxisome proliferator-activated receptor alpha activators on tumor necrosis factor expression in mice during endotoxemia.
Hill MR; Clarke S; Rodgers K; Thornhill B; Peters JM; Gonzalez FJ; Gimble JM
Infect Immun; 1999 Jul; 67(7):3488-93. PubMed ID: 10377130
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of apolipoprotein A5 gene expression by the nuclear receptor RORalpha.
Genoux A; Dehondt H; Helleboid-Chapman A; Duhem C; Hum DW; Martin G; Pennacchio LA; Staels B; Fruchart-Najib J; Fruchart JC
Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1186-92. PubMed ID: 15790933
[TBL] [Abstract][Full Text] [Related]
17. Developmental and pharmacological regulation of apolipoprotein C-II gene expression. Comparison with apo C-I and apo C-III gene regulation.
Andersson Y; Majd Z; Lefebvre AM; Martin G; Sechkin AV; Kosykh V; Fruchart JC; Najib J; Staels B
Arterioscler Thromb Vasc Biol; 1999 Jan; 19(1):115-21. PubMed ID: 9888873
[TBL] [Abstract][Full Text] [Related]
18. Atorvastatin and fenofibrate increase apolipoprotein AV and decrease triglycerides by up-regulating peroxisome proliferator-activated receptor-alpha.
Huang XS; Zhao SP; Bai L; Hu M; Zhao W; Zhang Q
Br J Pharmacol; 2009 Oct; 158(3):706-12. PubMed ID: 19694729
[TBL] [Abstract][Full Text] [Related]
19. Negative regulation of human fibrinogen gene expression by peroxisome proliferator-activated receptor alpha agonists via inhibition of CCAAT box/enhancer-binding protein beta.
Gervois P; Vu-Dac N; Kleemann R; Kockx M; Dubois G; Laine B; Kosykh V; Fruchart JC; Kooistra T; Staels B
J Biol Chem; 2001 Sep; 276(36):33471-7. PubMed ID: 11418615
[TBL] [Abstract][Full Text] [Related]
20. Antiepileptic Drug-Activated Constitutive Androstane Receptor Inhibits Peroxisome Proliferator-Activated Receptor
Shizu R; Otsuka Y; Ezaki K; Ishii C; Arakawa S; Amaike Y; Abe T; Hosaka T; Sasaki T; Kanno Y; Miyata M; Yamazoe Y; Yoshinari K
Mol Pharmacol; 2020 Nov; 98(5):634-647. PubMed ID: 32892155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
